Prolia 60 mg Alternative – Denosis (Denosumab) 60 mg Injection | Incepta Pharmaceuticals
Denosis 60 mg (Denosumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Prolia (Amgen).
Pack: 1 prefilled syringe. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Avastin 400 mg Alternative – Bevixa (Bevacizumab) 400 mg IV infusion | Incepta Pharmaceuticals
Bevixa 400 mg (Bevacizumab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Avastin (Roche).
Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Avastin 100 mg Alternative – Bevixa (Bevacizumab) 100 mg IV infusion | Incepta Pharmaceuticals
Bevixa 100 mg (Bevacizumab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Avastin (Roche).
Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Humira 40 mg Alternative – Advixa (Adalimumab) 40 mg Injection | Incepta Pharmaceuticals
Advixa 40 mg (Adalimumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Humira (AbbVie).
Pack: 1 prefilled syringe. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Evrenzo 100 mg Alternative – Renofix (Roxadustat) 100 mg Tablet | Everest Pharmaceuticals
Renofix 100 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 100 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 70 mg Alternative – Renofix (Roxadustat) 70 mg Tablet | Everest Pharmaceuticals
Renofix 70 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 70 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 50 mg Alternative – Renofix (Roxadustat) 50 mg Tablet | Everest Pharmaceuticals
Renofix 50 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Promacta / Revolade 50 mg Alternative – Elopag (Eltrombopag) 50 mg Tablet | Everest Pharmaceuticals
Elopag 50 mg (Eltrombopag) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Promacta / Revolade (Novartis). It belongs to the thrombopoietin receptor agonist class and is used in selected immune thrombocytopenia and aplastic anemia settings.
Active ingredient: Eltrombopag
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Cometriq 80 mg Alternative – Caboxen (Cabozantinib) 80 mg Capsule | Everest Pharmaceuticals
Caboxen 80 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.
Active ingredient: Cabozantinib
Strength: 80 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Lenvima 10 mg Alternative – Lenvaxen (Lenvatinib) 10 mg Capsule | Everest Pharmaceuticals
Lenvaxen 10 mg (Lenvatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lenvima (Eisai). It belongs to the multikinase inhibitor class and is used in selected thyroid, renal, liver and endometrial cancer regimens.
Active ingredient: Lenvatinib
Strength: 10 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Evrenzo 20 mg Alternative – Renofix (Roxadustat) 20 mg Tablet | Everest Pharmaceuticals
Renofix 20 mg (Roxadustat) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Evrenzo (Astellas). It belongs to the HIF-prolyl hydroxylase inhibitor class and is used in anemia associated with chronic kidney disease in jurisdictions where authorized.
Active ingredient: Roxadustat
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Megace 160 mg Alternative – Mezoxia (Megestrol acetate) 160 mg Tablet | Everest Pharmaceuticals
Mezoxia 160 mg (Megestrol acetate) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Megace (Bristol Myers Squibb). It belongs to the progestin class and is used in certain hormone-responsive cancer settings depending on formulation and jurisdiction.
Active ingredient: Megestrol acetate
Strength: 160 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.